Hepatitis B vaccine transnasal administration system
US12070497B2 · kind B2 · utility
0Cited by
2References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 4, 2019 |
| Grant date | Aug 27, 2024 |
| Priority date | — |
| Expiry date | Oct 4, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2730/10134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a rhinovaccination system for preventing and treating hepatitis B, comprising a hepatitis B vaccine composition for administration to nasal mucosa in combination with a medical nozzle device.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.